Niva Bupa Health Insurance Company Ltd
Incorporated in 2008, Niva Bupa Health Insurance Ltd is a Tech driven leading health insurer in India.[1]
- Market Cap ₹ 15,539 Cr.
- Current Price ₹ 84.4
- High / Low ₹ 109 / 61.0
- Stock P/E 72.8
- Book Value ₹ 20.7
- Dividend Yield 0.00 %
- ROCE 6.75 %
- ROE 7.33 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 40.5% CAGR over last 5 years
Cons
- Stock is trading at 4.08 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -0.55%
- Tax rate seems low
- Company has a low return on equity of 6.13% over last 3 years.
- Earnings include an other income of Rs.155 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Financial Services Financial Services Insurance General Insurance
Part of Nifty 500 BSE SmallCap BSE IPO BSE Allcap BSE Financial Services
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 1,057 | 1,413 | 2,114 | 3,165 | 4,196 | 5,374 | |
| 1,094 | 1,435 | 2,374 | 3,534 | 4,413 | 5,316 | |
| Operating Profit | -37 | -22 | -260 | -369 | -217 | 58 |
| OPM % | -3% | -2% | -12% | -12% | -5% | 1% |
| 0 | 0 | 90 | 413 | 329 | 155 | |
| Interest | 4 | 6 | 0 | 0 | 0 | 0 |
| Depreciation | 21 | 22 | 27 | 32 | 29 | 0 |
| Profit before tax | -62 | -50 | -197 | 13 | 82 | 214 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% |
| -62 | -50 | -197 | 13 | 82 | 214 | |
| EPS in Rs | 1.17 | |||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 38% |
| 3 Years: | 36% |
| TTM: | 28% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 40% |
| 3 Years: | 46% |
| TTM: | 161% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | 6% |
| Last Year: | 7% |
Balance Sheet
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1,126 | 1,350 | 1,409 | 1,511 | 1,700 | 1,827 |
| Reserves | -780 | -773 | -903 | -683 | 351 | 1,949 |
| 0 | 0 | 250 | 250 | 250 | 250 | |
| 891 | 1,322 | 1,983 | 2,799 | 3,891 | 6,453 | |
| Total Liabilities | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 10,479 |
| 39 | 46 | 49 | 52 | 58 | 75 | |
| CWIP | 2 | 2 | 1 | 4 | 1 | 0 |
| Investments | 1,067 | 1,622 | 2,401 | 3,366 | 5,458 | 8,175 |
| 129 | 230 | 287 | 455 | 675 | 2,228 | |
| Total Assets | 1,237 | 1,899 | 2,738 | 3,877 | 6,192 | 10,479 |
Cash Flows
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| 257 | 338 | 593 | 813 | 1,654 | ||
| -374 | -723 | -829 | -1,882 | -2,348 | ||
| 280 | 374 | 280 | 1,110 | 771 | ||
| Net Cash Flow | 164 | -12 | 43 | 41 | 78 |
Ratios
Figures in Rs. Crores
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | ||||||
| Days Payable | ||||||
| Cash Conversion Cycle | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Capital Days | -270 | -290 | -303 | -282 | -292 | -302 |
| ROCE % | -10% | -30% | 1% | 5% | 7% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
24 Jul - Earnings call scheduled on July 31, 2025, for Q1FY26 unaudited financial results.
-
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended June 30, 2025.
24 Jul - Board meeting on July 31 to approve Q1 June 2025 results; trading window closed till August 2.
- Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 22 Jul
-
Announcement under Regulation 30 (LODR)-Resignation of Director
21 Jul - Independent Director Sridhar Srinivasan resigns effective July 21, 2025, citing conflict of interest.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
14 Jul - Confirmation of no physical share certificates processed for quarter ended June 30, 2025.
Concalls
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT
Leading Insurance Company[1] Niva Bupa is the 3rd largest and the 2nd fastest growing standalone health insurer (SAHI) in India based on overall health gross direct premium income (GDPI) of Rs 5,494.43 crore in FY24 with an overall market share of 5.1%.